ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Research Network On Screening

August 6, 2010

Centers’ Problems Get Increasing Attention From Staff, Advisors

August 20, 1976

In Brief: David Harrington Replaces Zelen At ECOG; Kushnet To Receive Ewing Layman’s Award

December 1, 1989

Funding opportunities listed.

July 16, 2004

NCAB Committee Approves Concepts For Recompetition Of CIDAC, Two Other Contracts

July 1, 1983

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013